Pacific Biosciences of California Inc (PACB)
1.86
-0.13
(-6.53%)
USD |
NASDAQ |
May 07, 16:00
1.86
0.00 (0.00%)
After-Hours: 20:00
Pacific Biosciences of California Accounts Receivable (Quarterly): 36.62M for Dec. 31, 2023
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 36.62M |
September 30, 2023 | 30.49M |
June 30, 2023 | 24.03M |
March 31, 2023 | 29.59M |
December 31, 2022 | 18.79M |
September 30, 2022 | 22.76M |
June 30, 2022 | 27.06M |
March 31, 2022 | 27.85M |
December 31, 2021 | 24.24M |
September 30, 2021 | 23.95M |
June 30, 2021 | 19.94M |
March 31, 2021 | 12.91M |
December 31, 2020 | 16.84M |
September 30, 2020 | 11.81M |
June 30, 2020 | 11.35M |
March 31, 2020 | 7.325M |
December 31, 2019 | 15.27M |
September 30, 2019 | 9.966M |
June 30, 2019 | 12.12M |
March 31, 2019 | 7.279M |
December 31, 2018 | 8.595M |
September 30, 2018 | 6.404M |
June 30, 2018 | 7.446M |
March 31, 2018 | 8.452M |
December 31, 2017 | 13.43M |
Date | Value |
---|---|
September 30, 2017 | 8.897M |
June 30, 2017 | 9.525M |
March 31, 2017 | 10.44M |
December 31, 2016 | 11.42M |
September 30, 2016 | 11.76M |
June 30, 2016 | 10.43M |
March 31, 2016 | 8.009M |
December 31, 2015 | 5.245M |
September 30, 2015 | 4.164M |
June 30, 2015 | 3.95M |
March 31, 2015 | 5.287M |
December 31, 2014 | 3.406M |
September 30, 2014 | 2.37M |
June 30, 2014 | 4.255M |
March 31, 2014 | 3.383M |
December 31, 2013 | 2.746M |
September 30, 2013 | 3.814M |
June 30, 2013 | 4.104M |
March 31, 2013 | 2.009M |
December 31, 2012 | 2.008M |
September 30, 2012 | 0.532M |
June 30, 2012 | 3.371M |
March 31, 2012 | 1.505M |
December 31, 2011 | 4.557M |
September 30, 2011 | 4.434M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
7.325M
Minimum
Mar 2020
36.62M
Maximum
Dec 2023
20.15M
Average
19.94M
Median
Jun 2021
Accounts Receivable (Quarterly) Benchmarks
AtriCure Inc | 55.32M |
BioSig Technologies Inc | 0.024M |
Intellia Therapeutics Inc | 36.46M |
Shockwave Medical Inc | 114.55M |
Outset Medical Inc | 32.98M |